SEC Form 4 · accession 0001652252-17-000031
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Goetz
Officer — EVP, Chief Operating Officer
Period of report
May 10, 2017
Accepted (ET)
May 11, 2017 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | May 10, 2017 | M | 3,500 | $74.27 | A | 61,470 | D | |
| Bio-Rad A Common Stock | May 10, 2017 | F | 2,271 | $223.00 | D | 59,199 | D | |
| Bio-Rad A Common Stock | May 10, 2017 | M | 3,500 | $84.57 | A | 62,699 | D | |
| Bio-Rad A Common Stock | May 10, 2017 | F | 2,462 | $223.00 | D | 60,237 | D | |
| Bio-Rad A Common Stock | May 10, 2017 | M | 3,500 | $98.04 | A | 63,737 | D | |
| Bio-Rad A Common Stock | May 10, 2017 | F | 2,563 | $223.00 | D | 61,174 | D | |
| Bio-Rad A Common Stock | May 11, 2017 | M | 3,500 | $88.00 | A | 64,674 | D | |
| Bio-Rad A Common StockF2 | May 11, 2017 | S | 3,500 | $220.1686 | D | 61,174 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $74.27 | May 10, 2017 | M | 3,500 | D | — | Jun 10, 2019 | Bio-Rad A Common Stock | 3,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F4 | $84.57 | May 10, 2017 | M | 3,500 | D | — | Sep 8, 2020 | Bio-Rad A Common Stock | 3,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F5 | $98.04 | May 10, 2017 | M | 3,500 | D | — | Nov 4, 2021 | Bio-Rad A Common Stock | 3,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F6 | $88.00 | May 11, 2017 | M | 3,500 | D | — | Jun 11, 2018 | Bio-Rad A Common Stock | 3,500 | 0 | D |
Explanation of responses
- F1Includes 47.7598 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.35 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The option vested in five equal annual installments beginning on June 10, 2010.
- F4The option vested in five equal annual installments beginning on September 8, 2011.
- F5The option vested in five equal annual installments beginning on November 4, 2012.
- F6The option vested in five equal annual installments beginning on June 11, 2009.